Cabozantinib in patients with advanced Ewing sarcoma or osteosarcoma (CABONE): a multicentre,single-arm,phase 2 trial |
| |
| Affiliation: | 1. Early Phase Trials and Sarcoma Unit, Institut Bergonié, Bordeaux, France;2. Unité d''épidémiologie et de recherche cliniques, Institut Bergonié, Bordeaux, France;3. Department of Imaging, Institut Bergonié, Bordeaux, France;4. University of Bordeaux, Bordeaux, France;5. Department of Medicine, Institut Gustave Roussy, Villejuif, France;6. Department of Tumor Pediatrics, Institut Gustave Roussy, Villejuif, France;7. Inserm UMR 1219, Équipe Epicene, Bordeaux, France;8. Inserm CIC-EC 1401, Bordeaux, France;9. Department of Medical Oncology, Centre Oscar Lambret, University of Lille, Lille, France;10. Department of Tumor Pediatrics, Centre Oscar Lambret, University of Lille, Lille, France;11. Department of Medicine, Institut Curie, Paris, France;12. Department of Tumor Pediatrics, Institut Curie, Paris, France;13. Department of Medicine, Institut Cancerologie de l''Ouest, Nantes, France;14. Department of Medicine, Oncopole, Toulouse, France;15. Department of Medical Oncology, Assistance Publique des Hôpitaux de Marseille, Hôpital La Timone, Marseille, France;p. Department of Tumor Pediatrics, University Hospital Centre of Strasbourg, Strasbourg, France;q. Department of Medicine, Centre Antoine Lacassagne, Nice, France;r. Department of Medicine, Centre Leon Berard, Lyon, France;s. Department of Tumor Pediatrics, Centre Leon Berard, Lyon, France;t. Cancer Therapy Evaluation Program (CTEP), Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA;u. Immusmol, Bordeaux, France |
| |
| Abstract: | |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
